CD38's pleiotropic effects on NAD+ homeostasis, calcium signaling, and immune responses create therapeutic challenges. The debate identified this as a critical safety concern but provided no resolution for selective activation strategies. Source: Debate session sess_sda-2026-04-01-gap-v2-89432b95 (Analysis: sda-2026-04-01-gap-v2-89432b95)
Landscape Summary: Can systemic CD38 activation be achieved without triggering pro-inflammatory responses that accelerate neurodegeneration? is a 0.7 priority gap in neuropharmacology. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
Can systemic CD38 activation be achieved without triggering pro-inflammatory responses that accelerate neurodegeneration? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: